What's Going On With Polyrizon Shares Wednesday?
What's Going On With Polyrizon Shares Wednesday?
Polyrizon Ltd. (NASDAQ:PLRZ) shares are moving higher after the company announced it secured a manufacturing agreement with Eurofins CDMO Amatsiaquitaine.
Polyrizon有限公司（納斯達克：PLRZ）的股票在公司宣佈與Eurofins CDMO Amatsiaquitaine達成製造協議後上漲。
The Details: Under the agreement, Eurofins will supply Polyrizon with Clinical Trial Material (CTM) for its PL-14 allergy blocker trial.
詳細信息：根據協議，Eurofins將爲Polyrizon提供臨床試驗材料（CTM），以支持其PL-14過敏阻斷劑試驗。
The clinical trial, expected to commence in 2025, will evaluate the safety and efficacy of PL-14.
預計於2025年開始的臨床試驗將評估PL-14的安全性和有效性。
Tomer Izraeli, CEO of Polyrizon previously stated that, "We are pleased to have established this partnership with Eurofins CDMO Amatsiaquitaine S.A.S, which strengthens our preparation efforts for the upcoming PL-14 clinical trial. We believe that this collaboration marks a significant milestone in our journey toward providing effective allergy protection solutions to patients."
Polyrizon的首席執行官Tomer Izraeli之前表示：「我們很高興能與Eurofins CDMO Amatsiaquitaine S.A.S建立這一夥伴關係，這增強了我們爲即將到來的PL-14臨床試驗的準備工作。我們相信，這次合作標誌着我們在爲患者提供有效過敏保護解決方案的旅程中邁出了重要的一步。」
Polyrizon stock is trading on higher-than-normal volume at 72.09 million. The company's average session volume over the past 100 days is about 556.58 thousand.
Polyrizon股票的成交量超過正常水平，達到了7209萬。該公司過去100天的平均交易量約爲55.658萬。
PLRZ Price Action: At the time of writing, Polyrizon stock is trading 240.9% higher at $3.55, according to data from Benzinga Pro.
PLRZ價格走勢：根據Benzinga Pro的數據，截至寫作時，Polyrizon的股票交易價格爲$3.55，較前上漲240.9%。
Image: Michal Jarmoluk from Pixabay
圖片：來自Pixabay的Michal Jarmoluk